Tag: OGXI

Finance

Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

On 7 AUG OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced second quarter 2014 financial results. Revenue for the three and six months ended June 30, 2014 was $4.9 million and $16.7 million, respectively.  This compares with $6.3 million and $11.4 million, respectively, in the same periods in 2013. Revenue earned in the second quarter of 2014 consists of reimbursable clinical trial, manufacturing and preclinical costs incurred by … Continue reading Hot Watch List: OncoGenex Pharmaceuticals (NASDAQ:OGXI), Enanta Pharmaceuticals (NASDAQ:ENTA), Cheesecake Factory Incorporated (NASDAQ:CAKE), Randgold Resources Limited (NASDAQ:GOLD), OvaScience, Inc. (NASDAQ:OVAS)

Ryan Holtz
Finance

Morning Alert : NVIDIA Corporation (NASDAQ:NVDA), SandRidge Energy, Inc. (NYSE:SD), BioLife (NASDAQ:BLFS), Kelly Services, Inc. (NASDAQ:KELYA), OncoGenex Pharmaceuticals (NASDAQ:OGXI)

QUALCOMM, Inc. (NASDAQ:QCOM), NVIDIA Corporation (NASDAQ:NVDA) and Intel Corporation (NASDAQ:INTC) are the three new entrants that can significantly contribute in the Automotive Head-unit Processor Revenues. As per ABI Research, the three entrants can push the revenues to as much as $1.95 Billion by 2020. NVIDIA Corporation (NASDAQ:NVDA) belongs to Technology sector. Its net profit margin is 11.70% and weekly performance is 1.69%. On last trading … Continue reading Morning Alert : NVIDIA Corporation (NASDAQ:NVDA), SandRidge Energy, Inc. (NYSE:SD), BioLife (NASDAQ:BLFS), Kelly Services, Inc. (NASDAQ:KELYA), OncoGenex Pharmaceuticals (NASDAQ:OGXI)

Jayne Crisman
Finance

Big Movers: Cree (NASDAQ:CREE), JA Solar Holdings (NASDAQ:JASO), Chuy’s (NASDAQ:CHUY), OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI), Intercontinental Exchange (NYSE:ICE)

Cree, Inc. (Nasdaq: CREE), a market leader in LED lighting, today announced revenue of $436 million for its fourth quarter of fiscal 2014, ended June 29, 2014. This represents a 16% increase compared to revenue of $375 million reported for the fourth quarter of fiscal 2013, and an 8% increase compared to the third quarter of fiscal 2014. Cree, Inc. (NASDAQ:CREE) belongs to Technology sector. … Continue reading Big Movers: Cree (NASDAQ:CREE), JA Solar Holdings (NASDAQ:JASO), Chuy’s (NASDAQ:CHUY), OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI), Intercontinental Exchange (NYSE:ICE)

Jayne Crisman
Finance

Healthcare losers: Corcept Therapeutics Incorporated (NASDAQ:CORT), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Anika Therapeutics (NASDAQ:ANIK), Oncomed Pharmaceuticals (NASDAQ:OMED), Cesca Therapeutics (NASDAQ:KOOL)

Corcept Therapeutics Inc (NASDAQ:CORT) Director G Leonard Baker, Jr. bought 103,386 shares of the stock in a transaction that occurred on Wednesday, June 11th. The stock was purchased at an average cost of $2.32 per share, for a total transaction of $239,855.52. Following the completion of the transaction, the director now directly owns 578,389 shares of the company’s stock, valued at approximately $1,341,862. Corcept Therapeutics … Continue reading Healthcare losers: Corcept Therapeutics Incorporated (NASDAQ:CORT), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Anika Therapeutics (NASDAQ:ANIK), Oncomed Pharmaceuticals (NASDAQ:OMED), Cesca Therapeutics (NASDAQ:KOOL)

Richard Atkins
Finance

Healthcare Decliners: SunLink Health Systems, Inc. (NYSEMKT:SSY), Recro Pharma Inc (NASDAQ:REPH), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Retrophin Inc (NASDAQ:RTRX)

SunLink Health Systems Inc. (NYSEMKT:SSY) said that net loss for the third-quarter ended March 31, 2014 widened to $964,000 or $0.10 per share, from $186,000 or $0.02 per share last year. Loss from continuing operations for the quarter was $911,000 or $0.10 per share, compared to a loss from continuing operations of $197,000 or $0.02 per share in the prior year. Quarterly operating loss from … Continue reading Healthcare Decliners: SunLink Health Systems, Inc. (NYSEMKT:SSY), Recro Pharma Inc (NASDAQ:REPH), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Retrophin Inc (NASDAQ:RTRX)

Richard Atkins
BioTech

Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) shares plunged more than 48% pre-market after the company said results from its Phase 3 SYNERGY trial to add custirsen to standard first-line treatment of docetaxel/prednisone in men with metastatic prostate cancer failed to meet primary endpoints. The stock which was halted from trading ahead of the news, recently changed hands at $5.00, off an earlier low of $4.25. The shares … Continue reading Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)

Colin Pettis